The drug-induced degradation of oncoproteins: an unexpected Achilles' heel of cancer cells?

Cancer Discovery
Julien AblainH de Thé

Abstract

Many targeted therapies against cancer are aimed at inhibiting the enzymatic activity of kinases. Thus far, this approach has undoubtedly yielded significant clinical improvements, but has only rarely achieved cures. Other drugs, which selectively elicit proteasome-dependent degradation of oncoproteins, induce the loss of cancer cell self-renewal and promote cell differentiation and/or apoptosis. In acute promyelocytic leukemia, the cooperative degradation of PML/RARA by arsenic and retinoic acid cures most patients. In this condition and others, drug-induced proteolysis of oncoproteins is feasible and underlies improved clinical outcome. Several transcription factors, nuclear receptors, or fusion proteins driving cancer growth could be candidates for proteolysis-based drug-discovery programs.

References

Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·J ZhuH de Thé
Jan 7, 1998·Science·E H ChengJ M Hardwick
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·Z NawazB W O'Malley
Apr 6, 1999·The Journal of Experimental Medicine·V Lallemand-BreitenbachH de Thé
Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·J ZhuH de Thé
Apr 5, 2000·The Journal of Biological Chemistry·S HauserB M Spiegelman
Feb 8, 2002·Cell·Paolo Salomoni, Pier Paolo Pandolfi
Mar 4, 2003·Nature Reviews. Molecular Cell Biology·Masafumi Muratani, William P Tansey
Dec 19, 2003·Breast Cancer Research : BCR·Wenlin Shao, Myles Brown
Mar 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Zhi-Xiang ShenZhu Chen
Dec 21, 2004·International Journal of Cancer. Journal International Du Cancer·André Lopes CarvalhoLuiz Paulo Kowalski
Jun 14, 2005·Trends in Biochemical Sciences·Alexander Varshavsky
Jul 1, 2005·Nature·Franziska MichorMartin A Nowak
Oct 26, 2005·Breast Cancer Research and Treatment·Mitch DowsettRichard J Pietras
Mar 9, 2007·Nature·Christopher GreenmanMichael R Stratton
Mar 27, 2007·Nature Reviews. Cancer·Masao Matsuoka, Kuan-Teh Jeang
Sep 22, 2007·Journal of Cellular Physiology·Boris J CheskisLeonard P Freedman
Oct 12, 2007·Nature Reviews. Molecular Cell Biology·Rosa Bernardi, Pier Paolo Pandolfi
Oct 31, 2007·Proceedings of the National Academy of Sciences of the United States of America·Mirjam T EppingRené Bernards
Apr 15, 2008·Nature Cell Biology·Valérie Lallemand-BreitenbachHugues de Thé
May 13, 2008·Nature·Keisuke ItoPier Paolo Pandolfi
Jan 13, 2009·Nature·Christopher A MaherArul M Chinnaiyan
Feb 20, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jiong HuZhu Chen

❮ Previous
Next ❯

Citations

Mar 20, 2013·The Journal of Experimental Medicine·Julien AblainHugues de Thé
Jul 28, 2012·Science·Devendra SinghAntonio Iavarone
Dec 18, 2012·The Journal of Clinical Investigation·Francesco NiolaAnna Lasorella
Jun 6, 2012·Annual Review of Biochemistry·Alexander Varshavsky
Jun 20, 2014·Nature Communications·Umut SahinValérie Lallemand-Breitenbach
Dec 18, 2013·The Journal of Experimental Medicine·Guilherme Augusto Dos SantosPier Paolo Pandolfi
Jul 11, 2012·The Journal of Cell Biology·Hugues de ThéValérie Lallemand-Breitenbach
Dec 2, 2015·Journal of Proteome Research·Kohei KumeSatoshi S Nishizuka
Oct 15, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yasuhito AraiTatsuhiro Shibata
Aug 19, 2014·International Journal of Cancer. Journal International Du Cancer·Julien Ablain, Hugues de Thé
Jun 17, 2016·Molecular & Cellular Oncology·Lin Mei, Jean-Paul Borg
Dec 30, 2014·Molecular Aspects of Medicine·Alessandra di MasiClara Nervi
Jul 31, 2013·Blood·Valérie Lallemand-Breitenbach, Hugues de Thé
Jun 7, 2016·Cell Reports·Kaitlyn M GayvertOlivier Elemento
Jan 28, 2017·Scientific Reports·Huilin HuangLianghu Qu
Feb 9, 2017·EMBO Reports·Jiao WangJukka Westermarck
Apr 8, 2020·The FEBS Journal·Arda B Celen, Umut Sahin
Jul 28, 2016·Nature Reviews. Cancer·Scott Powers, Robert E Pollack

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis